Showing 1,561 - 1,580 results of 2,530 for search '"vaccines"', query time: 0.08s Refine Results
  1. 1561

    Retroviral and Lentiviral Vectors for the Induction of Immunological Tolerance by Inès Dufait, Therese Liechtenstein, Alessio Lanna, Christopher Bricogne, Roberta Laranga, Antonella Padella, Karine Breckpot, David Escors

    Published 2012-01-01
    “…They have been used for some time for gene therapy and the development of gene vaccines. Recently retroviral and lentiviral vectors have been used to generate tolerogenic dendritic cells, key professional antigen presenting cells that regulate immune responses. …”
    Get full text
    Article
  2. 1562

    Development and characterization of a reverse genetics system for the lineage II Chicava strain of Machupo virus in a guinea pig model. by Emily Mantlo, Junki Maruyama, John T Manning, Rachel A Reyna, Cheng Huang, Slobodan Paessler

    Published 2025-01-01
    “…<h4>Background</h4>Machupo virus (MACV) is a New World mammarenavirus (hereafter referred to as "arenavirus") and the etiologic agent of Bolivian hemorrhagic fever (BHF). No vaccine or antiviral therapy exists for BHF, which causes up to 35% mortality in humans. …”
    Get full text
    Article
  3. 1563

    Seroprevalence Study of Dengue at a Tertiary Care Hospital in Jaipur, Rajasthan by Ashina Singla, Afreen Ali, Himanshi Galav, Ved Prakash Mamoria

    Published 2024-05-01
    “…In the absence of specific treatments and vaccines for dengue fever (DF), vector control is the only method by which the spread of dengue can be prevented. …”
    Get full text
    Article
  4. 1564

    The Efforts to Implement a Malaria Elimination Strategy in The Highly Endemic Malaria Region of Papua Province, Indonesia by Erni Juwita Nelwan

    Published 2024-10-01
    “…Indonesia has recently completed a malaria vaccine trial, the IDSPZV1, which included the PfSPZ Vaccine and PfSPZ-CVac (CQ), conducted among soldiers deployed to Papua Province, New Guinea, for 10 months. …”
    Get full text
    Article
  5. 1565
  6. 1566
  7. 1567

    4-Aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure–property relationships and key biological targets by Angel H. Romero, Francisco Delgado

    Published 2025-01-01
    “…At the moment, there are neither approved vaccines nor effective drugs for the treatment of human leishmaniasis for any of its three typical clinical manifestations, and, importantly, the drugs of clinical use have several side effects, require complex administration regimens, present high cost, and are ineffective in many populations due to pathogen resistance. …”
    Get full text
    Article
  8. 1568

    Changes in the Profile of Antibiotic Prescriptions by Dentists in Brazil during the Pandemic by Fernando de Sá Del Fiol, Isaltino Pereira de Andrade-Jr, Marcus Tolentino da Silva, Silvio Barberato-Filho, Luciane Cruz Lopes, Cristiane de Cassia Bergamaschi

    Published 2022-01-01
    “…During the COVID-19 pandemic, people worldwide, including the scientific community, were insecure and fearful. The lack of vaccines at the beginning of the pandemic and the high mortality rate led to a search for alternative treatments for COVID-19. …”
    Get full text
    Article
  9. 1569
  10. 1570

    Single cell RNA sequencing improves the next generation of approaches to AML treatment: challenges and perspectives by Zahra Khosroabadi, Samaneh Azaryar, Hassan Dianat-Moghadam, Zohreh Amoozgar, Mohammadreza Sharifi

    Published 2025-01-01
    “…Generated data of the transcriptional profile of the AML could even allow the development of cancer vaccines and CAR T-cell therapies while saving valuable time and alleviating dangerous side effects of chemotherapy and HSCT in vivo. …”
    Get full text
    Article
  11. 1571

    A lyophilised formulation of chimpanzee adenovirus vector for long-term stability outside the deep-freeze cold chain by Frédéric Mathot, Edwige Lefebvre, Bernard G. Francq, Delphine Guillaume, Erwan Bourlès

    Published 2025-01-01
    “…Abstract Background The adenovirus-vaccine platform has come to prominence with the COVID-19 vaccination campaigns. …”
    Get full text
    Article
  12. 1572

    Method of obtaining and storing hyperimmune anthrax serum by S. V. Ivanova, L. A. Melnikova, A. P. Rodionov, V. V. Evstifeev

    Published 2023-09-01
    “…A live culture of Bacillus anthracis 55-VNIIVViM vaccine strain, used to produce live vaccines against animal anthrax, was used in the experiments. …”
    Get full text
    Article
  13. 1573

    Exploring the role and mechanisms of MAGEA4 in tumorigenesis, regulation, and immunotherapy by Weijian Zhu, Qiang Yi, Zheng Chen, Jiaqi Wang, Kui Zhong, Xinting Ouyang, Kuan Yang, Bowei Jiang, Jianing Zhong, Jinghua Zhong

    Published 2025-02-01
    “…MAGEA4-based TCR-T cell therapy and cancer vaccines show clinical potential. This article comprehensively reviews the structure and function of MAGEA4, as well as recent research progress in solid tumors, providing a theoretical foundation for the clinical translation of MAGEA4 and its application in immunotherapy.…”
    Get full text
    Article
  14. 1574

    Confidence intervals for the COVID-19 neutralizing antibody retention rate in the Korean population by Catherine Apio, Md. Kamruzzaman, Taesung Park

    Published 2020-09-01
    “…No specific therapeutic agents or vaccines for COVID-19 are available, though several antiviral drugs, are under investigation as treatment agents for COVID-19. …”
    Get full text
    Article
  15. 1575
  16. 1576

    Effect of attenueted parapoxvirus ovis on levels of some serum cytokines and antibody response in sheep by Kamil Atlı, Atilla Şimşek

    Published 2022-06-01
    “…<p> <b>Conclusion:</b> It was concluded that the vaccines against ORFV infection considered to be used in the future should be applied after the effects on the immune system have been clearly demonstrated.…”
    Get full text
    Article
  17. 1577

    Analysis of the Complete Genomes of Enterovirus 71 Subtypes in China by Lei Wang, Yuzhu Dai, Jun Cheng, Changgui Sun, Yu Chen, Dawei Cui

    Published 2021-01-01
    “…This study indicated that the major C4 and B5 subtypes will contribute to the development of vaccines and drugs of EV-A71 for prevention and monitoring of EV-A71-associated HFMD in China.…”
    Get full text
    Article
  18. 1578

    Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineages by Jingyun Yang, Xuemei He, Huashan Shi, Cai He, Hong Lei, Heng He, Li Yang, Wei Wang, Guobo Shen, Jinliang Yang, Zhiwei Zhao, Xiangrong Song, Zhenling Wang, Guangwen Lu, Jiong Li, Yuquan Wei

    Published 2025-01-01
    “…We further investigated humoral immune response of recombinant XBB vaccines against Omicron variants and estimated the neutralization resistance of JN.1 sublineages, including KP.2 and KP.3. …”
    Get full text
    Article
  19. 1579
  20. 1580

    Chiral polypeptide hydrogels regulating local immune microenvironment and anti-tumor immune response by Junfeng Ding, Tianran Wang, Zhiqiang Lin, Zhenyu Li, Jiaxuan Yang, Fujiang Li, Yan Rong, Xuesi Chen, Chaoliang He

    Published 2025-01-01
    “…Abstract The impact of chirality on immune response has attracted great interest in cancer vaccine research recently. However, the study of chiral synthetic polypeptide hydrogels as cancer vaccines as well as of the impact of biomaterials themselves for antitumor immunotherapy has rarely been reported. …”
    Get full text
    Article